Ionis Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
34.39
-1.48
(-4.126%)
Volume:
1,227,153
52 week range:
34.43 - 64.37
Market Cap:
4.854B
Company Description:
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Its scientific innovation began and continues with the knowledge that sick people depend on it, which fuels its vision of becoming one of the most successful biotechnology companies.